Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

× No keyword cloud information.

28 in total

Review 1. Oxidative mechanisms and tardive dyskinesia.

Authors: James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal: CNS Drugs Date: 2003 Impact factor: 5.749

2. Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.

Authors: Jeffrey K Yao; Ravinder Reddy
Journal: Antioxid Redox Signal Date: 2011-05-04 Impact factor: 8.401

3. Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

Authors: Michel C F Shamy; Clement Zai; Vincenzo S Basile; James L Kennedy; Daniel J Müller; Mario Masellis
Journal: Curr Pharmacogenomics Person Med Date: 2011-06-01

4. Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain.

Authors: Emilio L Streck; Gislaine T Rezin; Luciana M Barbosa; Lara C Assis; Eliane Grandi; João Quevedo
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2007-08-03 Impact factor: 3.000

Review 5. Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.

Authors: Josh Lister; José N Nobrega; Paul J Fletcher; Gary Remington
Journal: Psychopharmacology (Berl) Date: 2014-04-22 Impact factor: 4.530

Review 6. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors: C Mehler-Wex; P Riederer; M Gerlach
Journal: Neurotox Res Date: 2006-12 Impact factor: 3.911

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

Review 1. Oxidative mechanisms and tardive dyskinesia.

2. Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.

3. Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

4. Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain.

Review 5. Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.

Review 6. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Review 7. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

8. Genetic polymorphism of glutathione S-transferase T1 (GSTT1) and QT-interval in schizophrenia patients.

9. Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.

Review 10. Vitamin E in extrapyramidal disorders.